Search results for "228"

showing 10 items of 834 documents

Basic self-reports as an indicator of physical activity

2016

Introduction: Basic self-reports of physical activity (PA) has been applied by clinicians to identify whether adolescents with asthma are physically active. Aim: To investigate whether basic self-reports of PA in adolescents with and without asthma can be used as an indicator of PA with objective measures as criterion. Methods: One-hundred-and sixty (99 boys) adolescents (mean age 13.5 yrs) with (n=88) and without (n=72) asthma completed recordings of PA for three consecutive week-days and one weekend-day using the SenseWear TM Pro 2 Armband (BodyMedia Inc., Pittsburgh, PA). Cut off point defining moderate to vigorous intensity PA (MVPA) was 3 metabolic equivalents. Self-reported PA was ass…

medicine.medical_specialtyFuture studiesbusiness.industryPhysical activityMean agemedicine.diseaseExplained variationConfidence intervalMetabolic equivalent03 medical and health sciences0302 clinical medicineCut off point030228 respiratory systemmedicinePhysical therapy030212 general & internal medicinebusinesshuman activitiesAsthma7.2 Paediatric Asthma and Allergy
researchProduct

Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss …

2021

Abstract: Patients with obstructive sleep apnea (OSA) are at increased risk of developing metabolic disease such as diabetes. The effects of positive airway pressure on glycemic control are contradictory. We therefore evaluated the change in glycated hemoglobin (HbA1c) in a large cohort of OSA patients after long-term treatment with positive airway pressure. HbA1c levels were assessed in a subsample of the European Sleep Apnea Database [n=1608] at baseline and at long-term follow up with positive airway pressure therapy (mean 378.9 +/- 423.0 days). In a regression analysis, treatment response was controlled for important confounders. Overall, HbA1c decreased from 5.98 +/- 1.01% to 5.93 +/- …

medicine.medical_specialtyHbA1cCognitive Neuroscience03 medical and health sciencesBehavioral Neurosciencechemistry.chemical_compound0302 clinical medicinepositive airway pressure therapyWeight lossDiabetes mellitusInternal medicinePositive airway pressureWeight LossmedicinePrevalenceHumansGlycemicGlycated HemoglobinSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industrySleep apneaGeneral Medicinemedicine.diseasesleep apnearespiratory tract diseasesObesity MorbidObstructive sleep apnea030228 respiratory systemchemistryConcomitantCardiologyCpapGlycated hemoglobinHuman medicinemedicine.symptombusiness030217 neurology & neurosurgeryJournal of sleep research
researchProduct

Obstructive sleep apnea and Alzheimer’s disease-related cerebrospinal fluid biomarkers in mild cognitive impairment

2020

Abstract Previous studies have demonstrated that sleep-breathing disorders, and especially obstructive sleep apnea (OSA), can be observed in patients with a higher risk of progression to Alzheimer’s disease (AD). Recent evidence indicates that cerebrospinal fluid (CSF) AD-biomarkers are associated with OSA. In this study, we investigated these associations in a sample of patients with mild cognitive impairment (MCI), a condition that is considered the first clinical phase of AD, when patients showed biomarkers consistent with AD pathology. A total of 57 patients (mean age = 66.19; SD = 7.13) with MCI were included in the study. An overnight polysomnography recording was used to assess objec…

medicine.medical_specialtyHeart diseaseRapid eye movement sleeptau ProteinsPolysomnography03 medical and health sciences0302 clinical medicineAlzheimer DiseasePhysiology (medical)Internal medicinemedicineHumansCognitive DysfunctionAgedSleep Apnea ObstructiveAmyloid beta-Peptidesmedicine.diagnostic_testbusiness.industryApneamedicine.diseaseSleep in non-human animalsPeptide FragmentsObstructive sleep apnea030228 respiratory systemCardiologyNeurology (clinical)medicine.symptombusinessHypopneaBody mass indexBiomarkers030217 neurology & neurosurgerySleep
researchProduct

Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities

2017

medicine.medical_specialtyHepatologybusiness.industryPneumonia PneumocystisPNEUMOCYSTIS JIROVECIGastroenterologyInflammatory Bowel DiseasesPneumocystis cariniimedicine.diseaseInflammatory bowel diseaseGastroenterology03 medical and health sciencesPneumonia0302 clinical medicine030228 respiratory systemConcomitantInternal medicineHumansMedicine030211 gastroenterology & hepatologybusinessClinical Gastroenterology and Hepatology
researchProduct

The Contribution of Cell Blocks in the Diagnosis of Mediastinal Masses and Hilar Adenopathy Samples from Echobronchoscopy

2014

medicine.medical_specialtyHilar adenopathyLung Neoplasmsbusiness.industryGeneral Medicine03 medical and health sciences0302 clinical medicineText mining030228 respiratory system030220 oncology & carcinogenesisMediastinal DiseasesmedicineHumansRadiologybusinessLymphatic DiseasesCell blockArchivos de Bronconeumología (English Edition)
researchProduct

Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism

2018

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but feared long-term complication of acute pulmonary embolism (PE), although CTEPH may occur in patients with no history of symptomatic venous thromboembolism. It represents the most severe presentation of the so-called 'post-PE syndrome', a phenomenon of permanent functional limitations after PE caused by deconditioning after PE or ventilatory or circulatory impairment as a result of unresolved pulmonary artery thrombi. Because the post-PE syndrome may occur in up to 50% of PE survivors, and CTEPH tends to have an insidious and non-specific clinical presentation, CTEPH is often not diagnosed or diagnosed after a very long dela…

medicine.medical_specialtyHypertension Pulmonarymedicine.medical_treatmentHemodynamicsEndarterectomyPulmonary Artery030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsAngioplastyInternal medicinemedicine.arterymedicineHumansArterial PressureBlood CoagulationAntihypertensive Agentsbusiness.industryAnticoagulantsHematologymedicine.diseasePulmonary hypertensionPulmonary embolismTreatment Outcomemedicine.anatomical_structure030228 respiratory systemChronic DiseaseCirculatory systemPulmonary arteryCardiologyVascular resistancePulmonary EmbolismbusinessComplicationAngioplasty BalloonJournal of Thrombosis and Haemostasis
researchProduct

Hyperuricemia and non-dipping blood pressure

2013

Dear editor The strong association between the metabolic derangements that characterize the metabolic syndrome with arterial hypertension is very well-known, as it is the common finding of hyperuricemia in the patients with the metabolic syndrome. Besides, hyperuricemia has been found to be associated with cardiovascular, renal, and metabolic diseases; including not only gout but also type 2 diabetes mellitus, although its role as a risk factor is still debated.1 We were not aware of previous studies describing an association between uric acid levels and the non-dipping 24-hour blood pressure (BP) pattern, and for that reason we were intrigued by Tutal et al’s article, regarding hypertensiv…

medicine.medical_specialtyLetterInternational Journal of Nephrology and Renovascular Disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineHyperuricemiasleep apnea blood pressure uric acidbusiness.industrymedicine.disease3. Good healthGoutObstructive sleep apneaEndocrinologyBlood pressure030228 respiratory systemchemistryNephrologyUric acidMetabolic syndromebusinessHypopnea030217 neurology & neurosurgeryDyslipidemiaInternational Journal of Nephrology and Renovascular Disease
researchProduct

Positive Airway Pressure Treatment Reduces Glycated Hemoglobin (HbA1c) Levels in Obstructive Sleep Apnea Patients: Longitudinal Data from the Esada

2019

European-Respiratory-Society (ERS) International Congress -- SEP 28-OCT 02, 2019 -- Madrid, SPAIN

medicine.medical_specialtyLongitudinal dataGastroenterologyComorbidities03 medical and health sciencesHba1c levelchemistry.chemical_compound0302 clinical medicineDiabetes mellitusInternal medicinePositive airway pressuremedicine030212 general & internal medicinebusiness.industryType 2 Diabetes MellitusSleep apneaSystemic effectmedicine.diseaserespiratory tract diseasesObstructive sleep apnea030228 respiratory systemApnea–hypopnea indexchemistryCardiologyGlycated hemoglobinbusinessBody mass indexTurkish Thoracic Journal
researchProduct

The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma

2017

Introduction and Aim: As recognition of asthma heterogeneity increases and targeted treatment options are introduced, the future role of biomarkers (BM) in patient (pt) selection, monitoring and risk prediction will be important. We report baseline demographic and clinical characteristics from ARIETTA, an ongoing, prospective, longitudinal study assessing the relationship between BM and disease-related health outcomes in the real world. Methods: Pts with severe asthma (GINA steps 4-5) receiving daily inhaled corticosteroids (CS; fluticasone propionate ≥500 μg or equivalent) and ≥1 second controller medication were enrolled. Study enrollment is now complete. BM, clinical characteristics and …

medicine.medical_specialtyLongitudinal studyExacerbationbiologybusiness.industryLamaPeriostinbiology.organism_classificationmedicine.diseaseFluticasone propionate03 medical and health sciences0302 clinical medicine030228 respiratory systemInternal medicineClinical endpointmedicineIn patient030212 general & internal medicinebusinessAsthmamedicine.drugClinical Problems Asthma
researchProduct

Patterns and Predictors of Recovery from Poor Health Status Measured with the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test in Patient…

2019

Recent recommendations for chronic obstructive pulmonary disease (COPD) suggest that evaluation and management should focus on patient health status. Despite the frequency of poor health status and its negative impact on patients with COPD, little is known about how poor or non-poor health status persists and/or remits over time or what factors might predict recovery from a poor health status. The aim was to determine the likelihood of transitioning between poor and non-poor health status in patients with stable COPD followed for 2 years and to investigate factors that might predict recovery from poor health status. We prospectively included 137 patients with stable COPD (mean age, 66.9 yea…

medicine.medical_specialtyLongitudinal studyPulmonary diseaselcsh:Medicinehealth statusnon-smokerArticle03 medical and health sciencesrecovery0302 clinical medicineInternal medicinemedicineCOPDIn patient030212 general & internal medicineGeneralized estimating equationLungs -- DiseasesCOPDhandgrip strengthbusiness.industrylcsh:RPulmons -- MalaltiesCATGeneral MedicineOdds ratiomedicine.diseaseConfidence interval030228 respiratory systemCopd assessment testbusinesstransitionsJournal of Clinical Medicine
researchProduct